SUPPORT
PHYSICIAN PRESCRIBED METHADONE and BUPRENORPHINE
Build
on the success of the Waterbury Methadone Pilot Project. Using
a medical maintenance approach, allow physicians to prescribe methadone
in a medical office setting and dispense it through pharmacies
to stable, working patients.
The Waterbury Methadone
Pilot program demonstrated that functional status, drug use and the
use of health, legal and social services were comparable between the
patients in the medical maintenance treatment and the methadone clinic.
- 90%
of providers in the pilot were satisfied with treating patients,
compared with 74% of clinic providers.
- 73% of pilot patients felt
the quality of care they received was excellent, compared with 13%
of clinic patients.
- 95% of providers in the pilot felt that they
had a good or excellent rapport with the patient, compared with 83%
of the providers in the
clinic setting.
Methadone was created
as a long-term treatment for heroin addiction.
Buprenorphine is an opioid mixed agonist-antagonist that has been shown to
help reduce addiction to heroin and cocaine. Some physicians and patients prefer
one drug over the other, however both have significant bodies of evidence to
support their use.
Allowing physicians to prescribe methadone and
buprenorphine would help to de-stigmatize these treatment options for
heroin addiction.
Thus, normalizing them as any other prescription
to treat a disease such as insulin for diabetes, HIV/AIDS medications,
or medications used
to treat mental illness.
Expansion of this program would allow methadone patients greater
flexibility for treating their disease. With only 18 methadone clinics
in the state, location
alone forces some patients to travel a great distance. This impacts their ability
to work, deal with their children’s schedules and address other aspects of
their lives.
A key component of long-term recovery is staying away from the people
and places that addicts connect with using drugs. Allowing people to
receive treatment
from their primary care physician removes them from the clinic setting and
often, from the people they may have associated with during their addiction.